- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05987085
Medical Weight Loss on Pelvic Floor Dysfunction (WLPFD)
November 19, 2023 updated by: Zhijing Sun, Peking Union Medical College Hospital
Effect of Medical Weight Loss on Pelvic Floor Dysfunction: a Prospective Observational Study
The goal of this observational study is to learn about the effect of medical weight loss on the symptom of pelvic floor dysfunction in obese and overweight women.
The main question it aims to answer is: whether medical weight loss improves symptoms of pelvic floor dysfunctions in obese or overweight women.
Study Overview
Status
Recruiting
Conditions
Intervention / Treatment
Study Type
Observational
Enrollment (Estimated)
200
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Beijing
-
Beijing, Beijing, China, 100730
- Recruiting
- Peking Union Medical College Hospital
-
Contact:
- Zhijing Sun
- Phone Number: 19800312327
- Email: sunzhj2001@sina.com
-
Principal Investigator:
- Zhao Tian
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Yes
Sampling Method
Probability Sample
Study Population
Adult women seeking medical weight loss
Description
Inclusion Criteria:
- Age 18 or higher
- BMI 24 kg/m2 or higher
- Willing to follow the weight loss plan set by the physician follow-up and complete this study
Exclusion Criteria:
- Urinary tract infection or gynecologic reproductive system infection in the past month
- Treatment history of pelvic floor disorders
- Pregnancy or delivery in the past half year
- Women with severe systemic disease
- No follow-up conditions
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Pelvic floor symptoms before and after medical weight loss
Time Frame: At least half a year
|
At least half a year
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
To explore the related factors of symptom improvement in pelvic floor dysfunction
Time Frame: At least half a year
|
At least half a year
|
|
To explore the improvement of quality of life before and after medical weight loss
Time Frame: At least half a year
|
At least half a year
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
August 3, 2023
Primary Completion (Estimated)
December 1, 2024
Study Completion (Estimated)
December 1, 2024
Study Registration Dates
First Submitted
August 4, 2023
First Submitted That Met QC Criteria
August 4, 2023
First Posted (Actual)
August 14, 2023
Study Record Updates
Last Update Posted (Estimated)
November 21, 2023
Last Update Submitted That Met QC Criteria
November 19, 2023
Last Verified
August 1, 2023
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- WLPFD-PUMCH
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Weight Loss
-
United States Army Research Institute of Environmental...USDA Grand Forks Human Nutrition Research Center; Eastern Michigan UniversityCompletedWeight Loss | Bone Loss | Muscle LossUnited States
-
Case Comprehensive Cancer CenterUniversity Hospitals Seidman Cancer CenterRecruitingUnintentional Weight Loss and Cancer: A Prospective Trial of Patient-centered Weight Tracking CombinUnintended Weight LossUnited States
-
HealthPartners InstituteNational Cancer Institute (NCI)Completed
-
Zhen Jun WangUnknownSleeve Gastrectomy | Excessive Weight Loss | Total Weight Loss | Jejunojejunal Bypass | UncutChina
-
Dana-Farber Cancer InstituteCompletedWeight Loss Program After Cancer DiagnosisUnited States
-
Power Life Sciences Inc.Not yet recruitingGastric Bypass | Weight Loss Surgery
-
Medical University of ViennaCompleted
-
University at BuffaloHarvard Medical School (HMS and HSDM)TerminatedWeight Loss | Appetite LossUnited States
-
Duke UniversityNational Institute on Aging (NIA)Completed
-
Drexel UniversityUniversity of PennsylvaniaCompletedObesity | Overweight | Weight Loss MaintenanceUnited States
Clinical Trials on Diet and exercise
-
Göteborg UniversityThe Swedish Research Council; Swedish Council for Working Life and Social ResearchCompleted
-
Florida International UniversityTerminatedDiabetes | Frailty | Senior SyndromeUnited States
-
Rabin Medical CenterSoroka University Medical Center; D-Cure, IsraelCompleted
-
University of PittsburghUniversity of PennsylvaniaCompleted
-
USDA Grand Forks Human Nutrition Research CenterWithdrawn
-
Changi General HospitalCompletedQuality of Life | Inflammation | Sexual Dysfunction | Endothelial DysfunctionSingapore
-
Universidade Católica PortuguesaAssociação para o Desenvolvimento do Centro Académico de Investigação e Formação...Active, not recruitingCardiovascular Disease RiskPortugal
-
American Scitech InternationalProactive Clinical ResearchUnknownType II Diabetes MellitusUnited States, India
-
University of AlexandriaCompleted
-
University of Alabama at BirminghamNational Cancer Institute (NCI)Completed